NORGES BANK - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$26,710,776
+8.6%
822,123
+8.5%
0.00%0.0%
Q4 2023$24,603,275
+50.9%
757,490
+3.3%
0.00%
+33.3%
Q2 2023$16,308,805
+9.3%
732,980
+6.4%
0.00%0.0%
Q1 2023$14,924,433
-4.6%
689,032
-10.6%
0.00%
-25.0%
Q4 2022$15,647,799
-14.4%
770,448
+8.0%
0.00%
-20.0%
Q3 2022$18,287,140
+10.8%
713,227
+2.8%
0.01%
+25.0%
Q2 2022$16,499,159
-6.2%
693,825
-11.1%
0.00%0.0%
Q1 2022$17,581,859
+7.8%
780,722
-5.2%
0.00%
+33.3%
Q4 2021$16,307,000
-23.7%
823,602
-24.2%
0.00%
-40.0%
Q3 2021$21,380,000
+1.4%
1,086,402
+13.3%
0.01%0.0%
Q2 2021$21,091,000
-3.9%
958,675
+3.9%
0.01%0.0%
Q1 2021$21,940,000
-30.4%
922,254
-23.4%
0.01%
-28.6%
Q4 2020$31,510,000
+32.4%
1,204,498
-11.9%
0.01%
+16.7%
Q3 2020$23,805,000
-0.7%
1,367,712
-4.0%
0.01%
-14.3%
Q2 2020$23,975,000
+91.0%
1,425,396
+35.0%
0.01%
+75.0%
Q1 2020$12,550,000
-1.7%
1,055,5070.0%0.00%0.0%
Q4 2019$12,772,000
-14.4%
1,055,5070.0%0.00%
-20.0%
Q3 2019$14,920,000
+53.3%
1,055,507
+20.9%
0.01%
+66.7%
Q2 2019$9,732,000
+17.5%
872,858
+23.8%
0.00%0.0%
Q1 2019$8,280,000
-12.1%
705,3250.0%0.00%
-25.0%
Q4 2018$9,423,000
-4.7%
705,3250.0%0.00%
+33.3%
Q3 2018$9,888,000
+2.1%
705,325
+14.5%
0.00%0.0%
Q2 2018$9,684,000
+23.7%
616,025
+29.5%
0.00%0.0%
Q1 2018$7,826,000475,7610.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,372,001$98,287,0004.68%
TANAKA CAPITAL MANAGEMENT INC 79,574$934,0002.82%
Consonance Capital Management LP 3,747,453$43,995,0002.78%
S&T BANK/PA 613,740$7,205,0001.62%
AJ WEALTH STRATEGIES, LLC 595,834$6,995,0001.16%
Capital Impact Advisors, LLC 193,694$2,522,0001.12%
TEALWOOD ASSET MANAGEMENT INC 154,615$1,815,0000.77%
AMI ASSET MANAGEMENT CORP 722,932$8,487,0000.63%
Birchview Capital, LP 50,000$587,0000.37%
FEDERATED HERMES, INC. 11,176,281$131,210,0000.32%
View complete list of CORCEPT THERAPEUTICS INC shareholders